Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Kedoya Adyaraya Tbk owns and (RSGK) Fair Value & Analysis

Healthcare · ID · Market cap 567B IDR

Price870.00 IDR
Fair Value816.58 IDR
Upside-6.1%
Quality95/100
Evidence: High Range 612.44 IDR – 1,021 IDR

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

PT Kedoya Adyaraya Tbk owns and (RSGK) currently trades at 870.00 IDR, while our model-based Fair Value estimate is 816.58 IDR — implying the stock looks roughly 6.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

PT Kedoya Adyaraya Tbk owns and operates hospitals in Indonesia. It offers facilities, such as inpatient and outpatient services; and healthcare services, and building and operating hospitals. The company was founded in 1990 and is headquartered in Jakarta, Indonesia. PT Kedoya Adyaraya Tbk is a subsidiary of PT Sarana Meditama Metropolitan Tbk.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) +19% Fresenius SE (FSNUY) -24% 5225 (5225) -39% IHHHF (IHHHF) -57% Rede D'Or São Luiz S.A (RDOR3) +37% Tenet Healthcare Corporation (THC) +86%

Frequently asked questions

Is PT Kedoya Adyaraya Tbk owns and (RSGK) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 816.58 IDR versus a price of 870.00 IDR — about −6% (overvalued). Model-based estimate, not financial advice.
What is the fair value of RSGK?
Our 21-model fair value for PT Kedoya Adyaraya Tbk owns and is 816.58 IDR (as of Jun 24, 2026), built from audited fundamentals. The current price is 870.00 IDR.
What is the quality score of RSGK?
PT Kedoya Adyaraya Tbk owns and has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.